| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Added Clinical Value of 18F-FDG-PET/CT to Stage Patients With High-Risk Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy
|
van Ginkel, Noor
|
|
|
21 |
3 |
p. 342-348
|
article
|
| 2 |
Association of Androgen Deprivation Therapy with Metabolic Disease in Prostate Cancer Patients: An Updated Meta-Analysis
|
Swaby, Justin
|
|
|
21 |
3 |
p. e182-e189
|
article
|
| 3 |
A Systematic Review and Meta-Analysis of Clinicopathologic Factors Predicting Upper Urinary Tract Recurrence After Radical Cystectomy for Urothelial Bladder Cancer
|
Kardoust Parizi, Mehdi
|
|
|
21 |
3 |
p. 317-323
|
article
|
| 4 |
Development and Internal Validation of a Nomogram Predicting Overall Survival Based on Log ODDS of Positive Lymph-Nodes for Post Radical Cystectomy Patients in Muscle Invasive Carcinoma of Bladder
|
Patel, Keval N
|
|
|
21 |
3 |
p. e153-e165
|
article
|
| 5 |
Dose Intensity in Real-World Patients With Metastatic Renal Cell Carcinoma Taking Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors
|
Johnston, Hartlee
|
|
|
21 |
3 |
p. 357-365
|
article
|
| 6 |
Editorial Board
|
|
|
|
21 |
3 |
p. A1
|
article
|
| 7 |
Effect of Bisphosphonates on Skeletal Related Events in Long Bone Metastases of Renal Cell Carcinoma: A Systematic Review
|
van Broekhoven, Danique LM
|
|
|
21 |
3 |
p. e190-e197
|
article
|
| 8 |
Exploring Texture Analysis to Optimize Bladder Preservation in Muscle Invasive Bladder Cancer
|
Mehta, Prachi
|
|
|
21 |
3 |
p. e138-e144
|
article
|
| 9 |
Expression of RSUME is Associated With Poor Prognosis in Clear Cell Renal Carcinoma: Involvement of ROS Related Metabolism
|
Gonilski-Pacin, David
|
|
|
21 |
3 |
p. 393-402.e5
|
article
|
| 10 |
First-Line Lenvatinib Plus Pembrolizumab or Everolimus versus Sunitinib for Advanced Renal Cell Carcinoma: A United States-Based Cost-Effectiveness Analysis
|
Zhu, Youwen
|
|
|
21 |
3 |
p. 417.e1-417.e10
|
article
|
| 11 |
Five-Year Outcome and Safety in Patients Treated With Immune Checkpoint Blockade Therapies for Urothelial Carcinoma: Experience From Real-World Clinical Practice
|
Tural, Deniz
|
|
|
21 |
3 |
p. 334-341
|
article
|
| 12 |
Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate Cancer
|
George, Daniel J.
|
|
|
21 |
3 |
p. 383-392.e2
|
article
|
| 13 |
Incidence of Benign Renal Masses in a Contemporary Cohort of Patients Receiving Partial Nephrectomy for Presumed Renal Cell Carcinoma
|
Vijay, Varun
|
|
|
21 |
3 |
p. e114-e118
|
article
|
| 14 |
Local treatment Associated With Prognosis among Men With Metastatic Prostate Cancer: A SEER-Based Study
|
Zhou, Jiatong
|
|
|
21 |
3 |
p. e204-e215
|
article
|
| 15 |
Log Odds of Positive Lymph Nodes (LODDS) as an Independent Predictor of Overall Survival Following Radical Cystectomy in Urothelial Bladder Cancer: Time to Rethink Conventional Node Staging
|
Salari, Abolfazl
|
|
|
21 |
3 |
p. e175-e181
|
article
|
| 16 |
Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib
|
de Velasco, Guillermo
|
|
|
21 |
3 |
p. e166-e174
|
article
|
| 17 |
Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Registry (LACOG 0515)
|
Bastos, Diogo A.
|
|
|
21 |
3 |
p. e104-e113
|
article
|
| 18 |
Oligometastatic Hormone-Sensitive Prostate Cancer. Why Radiotherapy?
|
Arcos, Marta Barrado Los
|
|
|
21 |
3 |
p. e93-e103
|
article
|
| 19 |
Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer
|
Lim, Emerson A.
|
|
|
21 |
3 |
p. 366-375
|
article
|
| 20 |
Predictors of Pelvic Lymph Nodal Metastasis in Penile Squamous Cell Carcinoma- Results From a Matched-Pair Analysis
|
Sali, Akash P.
|
|
|
21 |
3 |
p. e119-e125
|
article
|
| 21 |
Prognostic Model for Clear-cell Renal Cell Carcinoma Based on Natural Killer Cell-related Genes.
|
Shi, Xuezhong
|
|
|
21 |
3 |
p. e126-e137
|
article
|
| 22 |
Role of Race and Insurance Status in Prostate Cancer Diagnosis-to-Treatment Interval
|
Nemirovsky, Daniel R.
|
|
|
21 |
3 |
p. e198-e203
|
article
|
| 23 |
Systemic Immune-inflammation Index (SII) During Induction has Higher Predictive Value Than Preoperative SII in Non-muscle-invasive Bladder Cancer Patients Receiving Intravesical Bacillus Calmette -Guerin
|
Deng-xiong, Li
|
|
|
21 |
3 |
p. e145-e152
|
article
|
| 24 |
Table of contents
|
|
|
|
21 |
3 |
p. A3-A7
|
article
|
| 25 |
Taxanes Versus Androgen Receptor Therapy as Second-Line Treatment for Castrate-Resistant Metastatic Prostate Cancer After First-Line Androgen Receptor Therapy
|
Broyelle, Antonin
|
|
|
21 |
3 |
p. 349-356.e2
|
article
|
| 26 |
The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease Management
|
Sacco, Matteo
|
|
|
21 |
3 |
p. 416.e1-416.e10
|
article
|
| 27 |
The Changing Landscape of Systemic Therapy in the Treatment of Synchronous Metastatic Hormone-sensitive Prostate Cancer
|
Lambert, Edward
|
|
|
21 |
3 |
p. 415.e1-415.e8
|
article
|
| 28 |
The Importance of Repeat Imaging Prior to Treatment Decision-making in Testicular Cancer: Commentary From the Inaugural Global Society of Rare Genitourinary Tumors Summit
|
McAlpine, Kristen
|
|
|
21 |
3 |
p. 418.e1-418.e6
|
article
|
| 29 |
The role of immune checkpoint inhibitors (ICI) as adjuvant treatment in renal cell carcinoma (RCC): A systematic review and meta-analysis
|
Monteiro, Fernando Sabino Marques
|
|
|
21 |
3 |
p. 324-333
|
article
|
| 30 |
Urinary Neuroendocrine Neoplasms Treated in the “Modern Era”: A Multicenter Retrospective Review
|
Le, Bryan Khuong
|
|
|
21 |
3 |
p. 403-414.e5
|
article
|
| 31 |
Variations in Penile Cancer Management: Results From the Global Society of Rare Genitourinary Tumors Survey
|
Prakash, Gagan
|
|
|
21 |
3 |
p. 376-382
|
article
|
Journal description